Apply Now
Deadline: May 8, 2026

U.S. Market Access Life Sciences

Enter the U.S. life sciences market.

U.S. | May 26 - October 31, 2026

Strengthen your U.S. commercialization readiness and stakeholder execution across customers, partners, payers, and investors.

Program Overview

The U.S. is one of the most attractive life sciences markets globally, with deep capital and strong partnership opportunities. Startups can build momentum quickly when the entry approach matches how the market makes decisions. With the right commercialization direction, strong clinical value can translate into real traction.

U.S. Market Access Life Sciences supports measurable progress by helping translate U.S. expansion priorities into a practical direction. The focus is on market access fundamentals (payers, reimbursement, patient flow, economics), regulatory readiness (FDA strategy and requirements), customer discovery and business development (who to target, where to start, and how to approach partnerships), and investor readiness that reflects U.S. expectations. The result is clearer decisions, stronger execution priorities, and a next-step plan that fits the realities of the U.S. market.

What You Get with U.S. Market Access Life Sciences

Save time and
money

Faster prioritization and fewer wrong turns.

Accelerate
growth

More momentum on U.S. life sciences milestones.

Build connections and partnerships

Stronger stakeholder conversations and BD direction.

Navigate
complexity

Clarity on reimbursement, regulatory, and legal essentials.

Is This Program Right for You?

Your company must be incorporated in Germany with one of the following legal forms: UG; AG; GmbH; GmbH & Co. KG. We also consider GbRs on a case-by-case basis

Qualify as a small and medium-sized enterprise (SME) based on the EU definition of a SME

Be under the limit of the official EU De-minimis aid regulation

Develop solutions in the Life Science sphere

What You Will Work On During the Program

These are some of the topics we will cover during the virtual program with the help of workshops and one-on-one mentoring sessions. This is just a sneak preview, there’s plenty of other things you will work on!

Strategy and Internationalization Readiness

Internationalization Mindset and Growth Fundamentals

Growth and success fundamentals for international expansion, including whether to internationalize, where, when, and how.

Messaging and Stakeholder Communication

Messaging and Storytelling

Problem statement, target market fit, and value proposition for U.S. stakeholder engagement and outreach.

Messaging and Stakeholder Communication

Crafting the Perfect Pitch

Pitching for diverse audiences, from investors and partners to collaborators, customers, and industry leaders.

Commercialization, Payers, and Market Access

De-Coding and Understanding Payers and Reimbursement

Reimbursement landscape, economics, patient flow, and reimbursement strategy considerations, including self-pay versus reimbursement models.

Regulatory and Legal Foundations

Navigating Regulatory Requirements

Strategy for FDA engagement, including requirements, cost, timing, and product-specific considerations.

Regulatory and Legal Foundations

Legal and IP Considerations for the U.S.

Market entry legal considerations, IP transfer, patent protection, and establishing a U.S. entity.

Customers, Partnerships, and Business Development

Customer Discovery

Segmentation and identification of target customers, accessible market, target geographies, key stakeholders, and acquisition planning.

Customers, Partnerships, and Business Development

Business Development and Partnerships

Business development and partnership opportunities, including approaches to relevant industry players and target health system stakeholders.

Investor Readiness and Conference Execution

Investor Mindset and Storytelling

Life sciences investor psychology, decision-making, and narratives that address regulatory pathway, market validation, and competitive positioning.

Investor Readiness and Conference Execution

Getting the Most Out of BD at Conferences

Pre-event planning, networking, pitch preparation, partnership identification, and post-conference follow-up.

What You'll Experience

A Market Access journey designed to translate U.S. life sciences priorities into execution, supported by expert guidance and targeted work on the fundamentals that drive traction.

Expert-Led Guidance

Practical sessions and mentoring across messaging, pitching, reimbursement, regulatory requirements, customer discovery, BD, and investor readiness.

Market Access and Compliance Clarity

Better decision-making grounded in payer and reimbursement dynamics, FDA engagement strategy, and legal and IP considerations.

Stakeholder-Ready Communication

Clearer U.S.-ready messaging and a pitch that works across partners, customers, investors, and industry stakeholders.

“Don’t let great science stall at market access. Turn your U.S. opportunity into an executable path to adoption, align your story, your pathway, and your stakeholder plan, and build traction with confidence.”

3-Phase Program Snapshot

Phase 1

Program Start and Preparation

Clarity on expansion goals, U.S. priorities, and the foundations required to move forward.

Phase 2

Execution with Expert Support

Work on messaging, pitching, reimbursement and regulatory readiness, customer discovery, BD, and investor storytelling.

Phase 3

After the Program (Next Steps)

Clear direction for the next U.S. milestones across commercialization, partnerships, and funding readiness.

Program Details

Location:

U.S.

Program Dates:

May 26 - October 31, 2026

In-Country Dates:

October 2026

Application Deadline:

May 8, 2026

Format:

Workshops, 1-1 Mentoring, Immersion Week

Cost:

Free

Test

Meet all Startup Stories

"I would say one of the things that really impressed me was the high profile of the experts that they German Accelerator introduced us to."

Read Story
Trinh Le-Fiedler
CEO & Co-Founder

"When it comes to choosing a startup accelerator for international expansion, Kellermann is clear: “In my opinion, I highly recommend German Accelerator,” he said."

Read Story
Julian Kellermann
Managing Director

"A ten-minute in-person meeting saved a lot of paperwork. Being physically present in Asia made all the difference."

Read Story
Otto Klemke
Co-Founder and CEO

"With our market plans to expand into the U.S., the mentors immensely helped us by giving deep insights on how to improve our pitch, our market focus and segmentation, our approach, and our communication and branding."

Read Story
Dr. Arne Kruse
Co-Founder

"It’s all about meeting the right people, so the German Accelerator network was most relevant to our success,” said Pentenrieder. “I’m excited to continue collaborating with that network."

Read Story
Martin Pentenrieder
Co-Founder
01

Submit Your Application

Submit your pitch deck along with answers to key questions about your business, including your vision, market-fit, and current growth stage. This information will help assess your company's potential for success and eligibility for the German Accelerator program.

02

Selection Process

Our team will carefully evaluate your application, reviewing all provided materials including your pitch deck and company details. If your startup is selected and meets the eligibility criteria, you will be notified of the next steps.

03

Ready, Set, Go!

Join the program and work hands-on via workshops, mentor sessions, and founder fireside chats - plus on-the-ground immersion to validate assumptions and define concrete next steps for market entry.

04

Know What to Do Next

With a clear expansion plan, hands-on execution support, and access to customer and partner, you’ll know exactly how to continue with your expansion. If you are ready, you can build on that success and identify where to grow next. Explore new markets and uncover further opportunities with Market Discovery, or scale in another market with Market Access.

Testimonials

What Previous Program Participants Say

Contact

Do You Have Any Questions?